ArticleBMC geriatrics2025
Cross-cultural adaptation and validation of the Arabic version of the SARC-F for evaluating sarcopenia in Saudi older adults.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07435272 (Kinesiophobia in Rheumatoid Arthritis), which is not on this map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Kinesiophobia in Rheumatoid Arthritis: Associations With Functional Disability, Disease Activity, and Related Clinical Factors
Who cites it
2 citing papers in PubMed.
- Exploring the Association of Polypharmacy and Depressive Symptoms with Sarcopenia in Older Adults.Journal of clinical medicine · 2026Article
- Translation, Cross-Cultural Adaptation, and Validation of the Croatian Version of the SARC-F Questionnaire for Assessing Sarcopenia in Older Adults.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveThe purpose of this study is to translate and cross-culturally adapt the SARC-F to Arabic and to assess the reliability and validity of the scale for use among community-dwelling older adults in Saudi Arabia.
methodsOlder adults aged 60 years and above were included. The translation and cross-cultural adaptation process followed standardized guidelines. Test-retest reliability and internal consistency were evaluated over two visits one week apart. Moreover, sensitivity, specificity, positive predictive value, and negative predictive value of the SARC-F were calculated. The validity of the Arabic version of the SARC-F was assessed against other measurements related to sarcopenia.
resultsA total of 182 community-dwelling older adults were enrolled (mean age = 65 ± 5.2 years). The internal consistency with the overall Cronbach's alpha was 0.71. For the test-retest reliability with a one-week interval, the ICC was 0.94. The Arabic SARC-F scale was significantly associated with other measurements related to sarcopenia. The sensitivity of the Arabic SARC-F ranged from 28 to 50%, and the specificity ranged from 81.4 to 82.9%.
conclusionThe SARC-F was successfully translated and adapted into the Arabic language. The Arabic SARC-F showed excellent reliability and adequate validity but revealed low sensitivity with high specificity across different sarcopenia definitions, which indicates that it can detect the absence of sarcopenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.